| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2865483 | The American Journal of the Medical Sciences | 2009 | 4 Pages |
Abstract
In conclusion, this open-label study in patients with postvagotomy gastroparesis patients reveals a reduction of gastroparetic symptoms at 1 and 3Â months after treatment with pyloric injection of botulinum toxin-A, with return of symptoms by 6Â months. Thus, botulinum toxin treatment does not produce a sustained reduction in gastroparetic symptoms in this clinical setting.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Savio C. MD, Shailender MD, Rajakumar MS, Teri A.H. RN, Mojtaba MD, Richard W. MD,